Facilitated By

San Antonio Medical Foundation

Development of a new, more effective live-attenuated influenza vaccine: an essential platform for future pandemic protection

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Martinez-Sobrido, Luis
Collaborating Institutions
University of Rochester
Funded by
Department of Defense
Research Start Date
Status
Active

The overall goal of this application is to develop a new, more effective live-attenuated influenza vaccine (LAIV) capable of eliciting broadly cross-protective immune responses to conserved internal viral proteins - thereby providing the basis for a universal influenza vaccine.

Collaborative Project
Drug Discovery
Infectious Disease